ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sequana Medical NV's annualizedNet Income for the quarter that ended in Jun. 2023 was €-32.93 Mil.
Sequana Medical NV's average Total Assets over the quarter that ended in Jun. 2023 was €25.58 Mil. Therefore, Sequana Medical NV's annualized ROA % for the quarter that ended in Jun. 2023 was -128.75%.
The historical rank and industry rank for Sequana Medical NV's ROA % or its related term are showing as below:
STU:2SE'
s ROA % Range Over the Past 10 Years
Min: -407.67 Med: -220.03 Max: -118.65
Current: -118.65
During the past 9 years, Sequana Medical NV's highest ROA % was -118.65%. The lowest was -407.67%. And the median was -220.03%.
STU:2SE's ROA % is ranked worse than 92.73% of 866
companies
in the Medical Devices & Instruments industry
Industry Median: -2.11
vs STU:2SE: -118.65
Sequana Medical NV ROA % Historical Data
The historical data trend for Sequana Medical NV's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sequana Medical NV's ROA %
For the Medical Devices subindustry, Sequana Medical NV's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sequana Medical NV's ROA % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's ROA % distribution charts can be found below:
* The bar in red indicates where Sequana Medical NV's ROA % falls into.
Sequana Medical NV ROA % Calculation
Sequana Medical NV's annualized ROA % for the fiscal year that ended in Dec. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jun. 2023) net income data.
ROA % is displayed in the 30-year financial page.
Sequana Medical NV (STU:2SE) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Jun. 2023) net income data. The Revenue data used here is two times the semi-annual (Jun. 2023) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Sequana Medical NV ROA % Related Terms
Thank you for viewing the detailed overview of Sequana Medical NV's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:2SE has been successfully added to your 